Melinta Therapeutics' Series E Round

Melinta Therapeutics raised a round of funding on July 06, 2011. Investors include Sanofi.

Melinta Therapeutics, formerly Rib-X Pharmaceuticals, is dedicated to the discovery, development and commercialization of groundbreaking antibiotics to overcome drug-resistant, life-threatening infect…

Articles about Melinta Therapeutics' Series E Round: